Ozempic maker Novo Nordisk prepared to enter India despite patent expiry, generic competition
Novo Nordisk’s GLP-1 drug Semaglutide, sold under brand names Ozempic and Wegovy, has been hailed as a miracle drug for ...
Novo Nordisk to cut price of Wegovy amid rising weight-loss drug competition
Novo Nordisk will slash the price of its blockbuster weight-loss drug Wegovy for cash-paying patients, after American rival ...
Down 39%. Is Novo Nordisk Stock a Buy on the Dip?
Despite falling hard since last summer, shares of Novo Nordisk have more than doubled the market's overall performance. The ...
USA Today13d
Shortage of popular drugs Wegovy and Ozempic is over, FDA says.
The Food and Drug Administration on Friday said the shortage of Novo Nordisk's weight-loss and diabetes drugs Wegovy and Ozempic is resolved, a move that could limit the availability of cheaper ...
Novo Nordisk Faces a Perfect Storm: Tariff Shock and Legal Battle Threaten Its Blockbuster Drugs
A looming trade war and a high-stakes lawsuit could shake up the future of Ozempic and Wegovy--here's what's at stake.
How Long Should I Stay on Ozempic For Weight Loss?
You know Ozempic can help with weight loss, but how long can you stay on Ozempic exactly? Unfortunately, there isn’t a solid ...
Fierce Pharma7h
In FDA obesity drug battle with compounders, Texas court allows Novo Nordisk to weigh in
As a federal court in Texas hears a case pitting the FDA versus compounders who want to continue to manufacture cheaper ...
BT Exclusive: We aim to compete cross all segments in obesity treatments, says Camilla Sylvest of Novo Nordisk
In an exclusive conversation with Business Today, Camilla Sylvest, Executive Vice President, Commercial Strategy & Corporate ...